EBS Technologies Reports That A Clinical Study Published In Neurology® Validates Electrical Brain Stimulation Technology Designed To Expand The Visual Field Of Patients With Impaired Vision

BERLIN--(BUSINESS WIRE)--EBS Technologies (“EBS”) announced today that a clinical study (“Brain functional connectivity network breakdown and restoration in blindness”) published in the highly respected journal Neurology® validates non-invasive brain stimulation for restoring partial vision to an impaired eye. The Company’s NEXT WAVE™ system is a non-invasive brain stimulation device that is designed to expand the visual field of patients with impaired vision caused by glaucoma or stroke or other neurological diseases. NEXT WAVE™ is approved for sale in Europe.

Help employers find you! Check out all the jobs and post your resume.